BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Dec 19, 2026; 16(12): 123228
Published online Dec 19, 2026. doi: 10.5498/wjp.123228
Clinical symptom complexity and treatment challenges in perinatal depression comorbid with anxiety or post-traumatic stress disorder
Ming-Juan Wu, Xin Xie
Ming-Juan Wu, Xin Xie, Department of Obstetrics, Affiliated Women’s Hospital of Jiangnan University, Wuxi 214002, Jiangsu Province, China
Author contributions: Wu MJ designed the research, collected and analyzed clinical data, and drafted the original manuscript; Xie X supervised the entire study, revised the manuscript, and was responsible for project administration and final approval of the published version. All authors read and approved the final manuscript.
AI contribution statement: This manuscript was independently written and developed by the authors without the use of any AI tools. All authors assume full responsibility for its originality and academic accuracy.
Institutional review board statement: This study was approved by the Affiliated Women’s Hospital of Jiangnan University, No. YLSL2026-074.
Informed consent statement: All study participants and their legal guardians provided written informed consent prior to study enrolment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Corresponding author: Xin Xie, Associate Chief Physician, Department of Obstetrics, Affiliated Women’s Hospital of Jiangnan University, No. 48 Huaishu Lane, Wuxi 214002, Jiangsu Province, China. xiexin0303@163.com
Received: June 30, 2026
Revised: July 27, 2026
Accepted: August 10, 2026
Published online: December 19, 2026
Processing time: 142 Days and 3.9 Hours
Abstract
BACKGROUND

Perinatal depression (PPD) is a leading cause of maternal disability worldwide and is frequently accompanied by anxiety and post-traumatic stress disorder (PTSD). These comorbid conditions are associated with poor maternal and infant outcomes; however, their clinical complexity and treatment responses remain insufficiently understood.

AIM

To investigate the clinical symptom complexity and treatment challenges associated with anxiety or PTSD co-occurring with PPD and to analyze factors influencing treatment outcomes.

METHODS

A total of 1024 perinatal women who attended the Affiliated Women’s Hospital of Jiangnan University between July 2020 and August 2025 were selected. Screening was conducted using the 9-item Patient Health Questionnaire Depression (PHQ-9), 7-item Generalized Anxiety Disorder scale, Childhood Trauma Questionnaire-Short Form, PTSD checklist for DSM-5, and City Birth Trauma Scale. Following diagnostic interviews using the Structured Clinical Interview for DSM-5 Disorders, PPD was confirmed in 154 patients, who were classified into the following groups: Depression alone (n = 70), depression comorbid with anxiety (n = 48), depression comorbid with PTSD (n = 22), and depression comorbid with both anxiety and PTSD (n = 14). Clinical characteristics were compared across the groups, and 96 patients who received a psychological intervention were followed up for 3 months. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of treatment failure.

RESULTS

Overall, 54.55% of the patients had comorbid anxiety or PTSD. Compared with the group with depression alone, the groups with depression comorbid with PTSD and depression comorbid with anxiety and PTSD had higher Childhood Trauma Questionnaire total scores (49.83 ± 13.64 and 52.16 ± 14.27 vs 38.24 ± 9.63; P < 0.05) and lower CEQ-2 total scores (2.13 ± 0.67 and 2.04 ± 0.71 vs 2.84 ± 0.62; P < 0.05). The group with depression comorbid with anxiety and PTSD had the highest PHQ-9 total score (21.36 ± 4.21) and higher scores for suicidal ideation than the other groups (P < 0.05). The overall treatment response rate was 56.82%, with the highest rate observed in the group with depression alone (71.43%) and the lowest rate observed in the group with depression comorbid with anxiety and PTSD (25.00%). Multivariate logistic regression analysis revealed that a history of childhood trauma [odds ratio (OR) = 3.50, 95% confidence interval (CI): 1.91-6.41], traumatic birth experiences (OR = 2.80, 95%CI: 1.60-4.89), low social support (OR = 2.31, 95%CI: 1.29-4.14), triple comorbidity (OR = 3.94, 95%CI: 1.80-8.62), and a baseline PHQ-9 score ≥ 15 (OR = 1.85, 95%CI: 1.05-3.25) were independent predictors of treatment failure (P < 0.05).

CONCLUSION

The clinical presentation of PPD comorbid with anxiety or PTSD is complex, and treatment remains challenging. Childhood trauma, traumatic birth experiences, low social support, triple comorbidity, and greater baseline depression severity significantly influence treatment outcomes; therefore, clinical practice should prioritize screening for comorbidities and early intervention for trauma.

Keywords: Perinatal depression; Comorbidity; Anxiety; Post-traumatic stress disorder; Childhood trauma; Birth trauma

Core Tip: Perinatal depression frequently co-occurs with anxiety or posttraumatic stress disorder, forming a high risk clinical profile marked by greater symptom severity and markedly lower treatment response rates-particularly in cases with triple comorbidity. Childhood trauma, traumatic birth experiences, low perceived social support, and severe baseline depression independently predict poor outcomes. Routine screening for these comorbidities, paired with traumainformed assessment of early life and obstetric experiences, is essential to guide personalized interventions and optimize maternal and infant prognosis.

Write to the Help Desk